ArticlePediatric nephrology (Berlin, Germany)2018

Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome.

Franca Iorember et al.PubMed ↗Publisher ↗

No numbers read from the abstract.